• Tioconazole Workflows for Antifungal Research

  2026-09-23

  Build more interpretable Tioconazole experiments by pairing dose-response testing with solvent-matched controls and an orthogonal viability readout. This guide connects its ergosterol-targeting rationale to practical in vitro workflows while clearly separating antifungal evidence from an unrelated leukemia study used only as a lesson in experimental context.

• Dasatinib Monohydrate and NET Assay Design

  2026-09-23

  Dasatinib Monohydrate research can extend beyond kinase inhibition into CML-associated neutrophil extracellular trap biology. This article connects BMS-354825 pharmacology with NET assay design, resistance modeling, and evidence-based interpretation of vascular inflammation endpoints.

• KR-12 Charge Placement and Membrane Activity

  2026-09-22

  The reference study shows that KR-12 activity depends not only on total cationic charge but also on where each basic residue sits within its amphipathic helix. Alanine scanning and membrane assays identify distinct roles for interfacial and helix-face residues, providing a framework for rational engineering of LL-37-derived antimicrobial peptides.

• Erastin Ferroptosis Inducer: Applied Workflows

  2026-09-22

  Build reproducible ferroptosis assays with Erastin by controlling stock preparation, exposure timing, oxidative-stress readouts, and cell-line context. A recent study also shows how BRD4 inhibition can sensitize diverse models, creating a practical framework for combination screening and FSP1-focused mechanism studies.

• Flubendazole Workflows for Autophagy Research

  2026-09-21

  Flubendazole provides a DMSO-soluble way to probe autophagy alongside cellular metabolism, with practical value in controlled pathway and phenotype assays. This guide translates liver-fibrosis metabolism findings into robust experimental workflows while separating established evidence from hypothesis-generating applications.

• Gap19: Selective Connexin 43 Hemichannel Blocker

  2026-09-21

  Gap19 enables selective Cx43 hemichannel inhibition while preserving gap junction channel function, supporting experiments in astrocyte ATP signaling, ischemic brain injury, and inflammatory macrophage polarization. This guide connects mechanism to executable workflows, controls, dosing logic, and troubleshooting.

• Ibrutinib (PCI-32765): A BTK Assay Framework

  2026-09-20

  Explore how PCI-32765 (Ibrutinib) enables mechanistic studies of BTK, B-cell receptor signaling, and chronic lymphocytic leukemia research. This guide also explains how ATRX-stratified glioma findings can inform assay design without overstating cross-domain evidence.

• Epalrestat Workflows for Oxidative Stress Research

  2026-09-19

  Epalrestat connects aldose reductase and polyol pathway inhibition with KEAP1/Nrf2-centered neuroprotection workflows. This guide translates recent Parkinson’s disease model findings into practical cell, binding, mitochondrial, and animal-study strategies while addressing solubility and reproducibility challenges.

• Bradford Protein Assay Kit: Practical Protocol

  2026-09-18

  The Bradford Protein Assay Kit (SKU K4103) provides rapid protein concentration measurement from small-volume solution samples using Coomassie dye and absorbance at 595 nm. It is suited to routine enzyme, purification, and molecular biology workflows, but should not be treated as a protein purity test or used without compatibility checks for detergent-containing buffers.

• Mtb–BMX Signaling Blocks Lysosomal Acidification

  2026-09-18

  The reference study identifies a host–pathogen mechanism in which Mycobacterium tuberculosis secretes Chp2/Rv1184 to promote BMX-dependent phosphorylation of ATP6V1E1, disrupting V-ATPase assembly and lysosomal acidification. The findings connect a specific host kinase to intracellular Mtb survival and provide a rationale for evaluating BMX inhibition in host-directed tuberculosis models.

• Epalrestat Workflows for Oxidative Stress Research

  2026-09-17

  Epalrestat combines aldose reductase inhibition with a mechanism-linked KEAP1/Nrf2 research hypothesis, making it useful for connecting polyol pathway biology, oxidative stress, and neuronal injury. This practical guide covers solvent handling, cell and animal model design, orthogonal validation, and troubleshooting for diabetic neuropathy research and Parkinson’s disease model workflows.

• Anlotinib Hydrochloride: From Assay to Evidence

  2026-09-17

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor that connects receptor-level signaling, endothelial phenotypes, and translational cancer research. This guide explains how to interpret its anti-angiogenic activity without confusing pathway inhibition with clinical proof.

• Propidium Iodide Workflows for Cell Death Studies

  2026-09-16

  Build more informative viability, apoptosis, and cell cycle assays with Propidium iodide, from routine flow cytometry to host–pathogen models. This guide translates the GRA12 virulence study into practical membrane-integrity readouts while emphasizing controls, gating, and interpretation limits.

• SERT–nNOS Blockade and Fast-Onset Antidepressant Action

  2026-09-16

  The reference study identifies disruption of the serotonin transporter–neuronal nitric oxide synthase (SERT–nNOS) complex as a strategy for accelerating antidepressant responses. Using mBRET screening, stress-based mouse models, behavioral testing, and rs-fMRI, the authors show that esflurbiprofen modifies dorsal raphe nucleus circuitry and produces rapid antidepressant-like effects.

• Epalrestat Workflows for Polyol Pathway Research

  2026-09-15

  Build reproducible aldose reductase inhibition studies across diabetic neuropathy research, oxidative stress research, and emerging cancer-metabolism models. This guide connects Epalrestat preparation, pathway-focused controls, quantitative readouts, and troubleshooting to the fructose-metabolism framework described in recent cancer research.

7658 records 1/511 page Next 12345 下5页 Last page